R&O: "Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation" https://t.co/h6KXam4fON
R&O: "Comparison the acute toxicity of two different induction chemotherapy schedules with cisplatin and fluorouracil in nasopharyngeal carcinoma patients" https://t.co/nAysdhLZlH
R&O: "CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T" https://t.co/wFqvDX7Prf
R&O: "No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis" https://t.co/4IVRjI5Es5
R&O: "Prognostic and predictive values of baseline and mid-treatment FDG-PET in oropharyngeal carcinoma treated with primary definitive (chemo)radiation and impact of HPV status: Review of current literature and emerging roles" https://t.co/7n2HFJwqon
R&O: "Comprehensive dose evaluation of a Deep Learning based synthetic Computed Tomography algorithm for pelvic Magnetic Resonance-only radiotherapy" https://t.co/aRnpZEP8OE
R&O: "Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study" https://t.co/WilIVQQ7Nw
R&O: "EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study" https://t.co/NhfzgA1KuM
IJROBP: "Leveling Up the Access to Radiation Therapy in Latin America: Economic Analysis of Investment, Equity, and Inclusion Opportunities Up to 2030" https://t.co/afQdAkIkVn
IJROBP: "Challenges to Improving Access to Stereotactic Body Radiation Therapy and Radiosurgery in the Philippines: A Case Study for Lower-Middle Income Countries" https://t.co/ura71NhWDe
IJROBP: "Radiation Therapy and Indigenous Peoples in Canada and Australia: Building Paths Toward Reconciliation in Cancer Care Delivery" https://t.co/GW4rXWEwhb